AU1678900A - A novel liposomal formulation useful in treatment of cancer and other proliferation diseases - Google Patents
A novel liposomal formulation useful in treatment of cancer and other proliferation diseasesInfo
- Publication number
- AU1678900A AU1678900A AU16789/00A AU1678900A AU1678900A AU 1678900 A AU1678900 A AU 1678900A AU 16789/00 A AU16789/00 A AU 16789/00A AU 1678900 A AU1678900 A AU 1678900A AU 1678900 A AU1678900 A AU 1678900A
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- treatment
- liposomal formulation
- formulation useful
- proliferation diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2337DE1998 | 1998-08-11 | ||
| IN2337/DEL/98 | 1998-08-11 | ||
| PCT/IN1999/000037 WO2000009071A2 (en) | 1998-08-11 | 1999-08-10 | A novel liposomal formulation useful in treatment of cancer and other proliferation diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1678900A true AU1678900A (en) | 2000-03-06 |
Family
ID=11092773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU16789/00A Abandoned AU1678900A (en) | 1998-08-11 | 1999-08-10 | A novel liposomal formulation useful in treatment of cancer and other proliferation diseases |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1678900A (en) |
| WO (1) | WO2000009071A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001041738A2 (en) * | 1999-12-10 | 2001-06-14 | Celator Technologies Inc. | Lipid carrier compositions with protected surface reactive functions |
| CA2401340A1 (en) * | 2000-02-28 | 2001-09-07 | The University Of British Columbia | Compositions and methods for the treatment of inflammatory disease using topoisomerase inhibitors |
| US8658203B2 (en) | 2004-05-03 | 2014-02-25 | Merrimack Pharmaceuticals, Inc. | Liposomes useful for drug delivery to the brain |
| KR101223366B1 (en) | 2004-05-03 | 2013-01-16 | 헤르메스 바이오사이언스, 인코포레이티드 | Liposomes useful for drug delivery |
| JP2008535927A (en) | 2005-04-12 | 2008-09-04 | ウィスコンシン アルムニ リサーチ ファンデイション | Polymer and passenger drug micelle composition |
| WO2011038278A2 (en) | 2009-09-25 | 2011-03-31 | Wisconsin Alumni Research Foundation | Micelle encapsulation of therapeutic agents |
| BR122021024957B1 (en) | 2015-10-16 | 2023-12-12 | Ipsen Biopharm Ltd | Processes for producing a storage-stabilized liposomal irinotecan composition |
| CN111701026B (en) * | 2020-06-28 | 2022-10-21 | 吴燕 | Anti-tumor combined drug nano-carrier and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR910014122A (en) * | 1990-01-19 | 1991-08-31 | 디께다 가즈히꼬 | Lyophilized Formulation of Etoposide-2-dimethylamino Compound |
| US5534499A (en) * | 1994-05-19 | 1996-07-09 | The University Of British Columbia | Lipophilic drug derivatives for use in liposomes |
| US5741516A (en) * | 1994-06-20 | 1998-04-21 | Inex Pharmaceuticals Corporation | Sphingosomes for enhanced drug delivery |
| US6214388B1 (en) * | 1994-11-09 | 2001-04-10 | The Regents Of The University Of California | Immunoliposomes that optimize internalization into target cells |
-
1999
- 1999-08-10 AU AU16789/00A patent/AU1678900A/en not_active Abandoned
- 1999-08-10 WO PCT/IN1999/000037 patent/WO2000009071A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000009071A2 (en) | 2000-02-24 |
| WO2000009071A3 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6952896A (en) | Method for treatment of cancer and infectious diseases and compositions useful in same | |
| AU3890297A (en) | Herbal formulation and therapeutic uses therefor | |
| AUPN698495A0 (en) | Improved therapeutic formulation and method | |
| AU1568899A (en) | Massage and skin suction apparatus | |
| AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
| AU7907300A (en) | Novel combination of loteprednol and antihistamines | |
| AU3068699A (en) | Skin equivalent and methods of forming and using same | |
| AU1164601A (en) | Therapeutic use and formulation | |
| AU6435398A (en) | Prevention and treatment of hepatocellular cancer | |
| AU7058000A (en) | 13 human colon and colon cancer associated proteins | |
| AU1678900A (en) | A novel liposomal formulation useful in treatment of cancer and other proliferation diseases | |
| AUPQ201499A0 (en) | Treatment of inflammatory and malignant diseases | |
| AU6968098A (en) | Topical treatment of skin diseases and eye afflictions | |
| AU2587195A (en) | Growth hormone therapy and related methods and pharmaceutical compositions | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
| AU1068499A (en) | Injection-moldable composition and article of manufacture comprising same | |
| AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
| AU6111800A (en) | 26 human prostate and prostate cancer associated proteins | |
| AU2512495A (en) | Therapeutic phenoxyalkylazoles and phenoxyalkylazines | |
| IL123156A0 (en) | Benzenesulphonamide derivatives their preparation and their application in therapy | |
| AU2001276462A1 (en) | Use of natural products in cancer treatment | |
| AU3361595A (en) | Formulation and use of carotenoids in treatment of cancer | |
| AU5697996A (en) | Peptidyl compounds and their therapeutic use | |
| AU2905995A (en) | Brefeldin A derivatives and their utility in the treatment of cancer | |
| AU5871898A (en) | Microparticles and their use in cancer treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |